Allogene Therapeutics Inc (ALLO) options traded 280 contracts on Nov 4, 2026, below the 20-day average of 339. Calls made up 89.3% of the volume, a put/call ratio of 0.12.
Option Volume by Strike
Showing results for ALLO, 2026-11-20(m), calls & puts
Option Volume Stats
Showing results for ALLO, 2026-11-20(m), calls & puts
| Call Volume | |
|---|---|
| Put Volume | |
| Volume Total | |
| Put-Call Volume Ratio |
Highest Volume Options
Showing results for ALLO, 2026-11-20(m), calls & puts
Option Volume Total by Expiry
Showing results for ALLO, 2026-11-20(m), calls & puts. View all expiries
Option Volume History
Showing daily totals for ALLO, all expirations, calls & puts. View full history
ALLO Option Volume FAQ
What is option volume?
Option volume is the number of option contracts traded during a session. It resets at the start of each trading day.
How many ALLO options traded on Nov 4, 2026?
250 calls and 30 puts traded on Nov 4, 2026, 280 contracts in total.
Is ALLO option volume higher than usual?
Volume on Nov 4, 2026 was below the 20-day average of 339 contracts. The busiest of the last 20 sessions was Oct 28, 2026, with 1.13K contracts. The 30-day average is 316. See the ALLO option volume history for a longer view.
What is the ALLO put/call volume ratio?
The Allogene Therapeutics put/call volume ratio was 0.12 on Nov 4, 2026. Over the last 20 sessions it averaged 0.20, so calls outnumber puts over that stretch.
What is Allogene Therapeutics Inc?
Allogene Therapeutics Inc is a clinical stage immuno-oncology company pioneering the development of genetically engineered allogeneic T cell product candidates for the treatment of cancer and autoimmune diseases.